Abrupt development of sarcoidosis with a prodromal increase in plasma osteopontin in a patient with rheumatoid arthritis during treatment with etanercept

Journal of Rheumatology

Volumn 37, Issue 1, 2010, Pages 210-211

  Takatori, Shino ^a   Kamata, Yasuyuki ^a   Murosaki, Takamasa ^a   Iwamoto, Masahiro ^a   Minota, Seiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTARIT; ADALIMUMAB; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; ETANERCEPT; GAMMA INTERFERON; GOLD SALT; HEMOGLOBIN; INFLIXIMAB; LEFLUNOMIDE; LYSOZYME; METHOTREXATE; MIZORIBINE; NITROGEN; OSTEOPONTIN; PREDNISONE; SALAZOSULFAPYRIDINE; SOLUBLE INTERLEUKIN 2 RECEPTOR; UREA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD LEVEL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CREATININE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG DOSE INCREASE; EDEMA; FEMALE; FEVER; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LETTER; MALAISE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PRURITUS; REMISSION; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SCINTIGRAPHY; SPUTUM CULTURE; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; OSTEOPONTIN; RECEPTORS, TUMOR NECROSIS FACTOR; SARCOIDOSIS;

EID: 73649128276     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090647     Document Type: Letter

References (8)

1. Saleh S, Ghodsian S, Yakimova V, Henderson J, Sharma OP. Effectiveness of infliximab in treating selected patients with sarcoidosis. Respir Med 2006;100:2053-9.
2. Utz JP, Limper AH, Kalra S, Specks U, Scott JP, Vuk-Pavlovic Z, et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 2003;124:177-85.
3. Peno-Green L, Lluberas G, Kingsley T, Brantley S. Lung injury linked to etanercept therapy. Chest 2002;122:1858-60.
4. Phillips K, Weinblatt M. Granulomatous lung disease occurring during etanercept treatment. Arthritis Rheum 2005;53:618-20.
5. O'Shea FD, Marras TK, Inman RD. Pulmonary sarcoidosis developing during infliximab therapy. Arthritis Rheum 2006;55:978-81.
6. Verschueren K, Van Essche E, Verschueren P, Taelman V, Westhovens R. Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients. Clin Rheumatol 2007;26:1969-71.
7. Koguchi Y, Kawakami K, Uezu K, Fukushima K, Kon S, Maeda M, et al. High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Am J Respir Crit Care Med 2003;167:1355-9.
8. Carlson I, Tognazzi K, Manseau EJ, Dvorak HF, Brown LF. Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology. Lab Invest 1997;77:103-8.